VVUS

VIVUS, Inc. News Headlines

$2.57
*  
0.08
3.21%
Get VVUS Alerts
*Delayed - data as of Mar. 27, 2015  -  Find a broker to begin trading VVUS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By



Has Orexigen Delivered A Death Knell To Vivus?
3/27/2015 10:37:00 AM - Seeking Alpha


Orexigen: Contrave Gathering Momentum
3/23/2015 4:51:00 PM - Seeking Alpha




Vivus: Qsymia Sales Slip, Company Needs To Shift Into Gear
3/23/2015 6:51:00 AM - Seeking Alpha














Vivus - Qsymia Scripts Pass 11,000 For First Time In 2015
3/13/2015 5:44:00 PM - Seeking Alpha








Orexigen Should Pull Through The Current Bad Publicity
3/11/2015 2:05:00 PM - Seeking Alpha


Vivus: Teva Wants To Make Generic Qsymia - Can This Be Good?
3/11/2015 11:02:00 AM - Seeking Alpha


Orexigen - Contrave Sales Continue Up
3/11/2015 9:34:00 AM - Seeking Alpha


4 Stocks Under $10 Making Big Moves Higher
3/10/2015 1:51:00 PM - TheStreet








Orexigen: It'll All Blow Over, Buy On Dips
3/9/2015 4:14:00 PM - Seeking Alpha